BrightHeart, a global leader in AI-driven prenatal ultrasound, announced that its B-Right AI Platform is now available through GE HealthCare’s Voluson Solution Store, bringing advanced AI support directly into routine prenatal exams. This collaboration is designed to improve early detection of congenital defects, reduce diagnostic uncertainty, and support better outcomes for clinicians, expectant parents, and babies.
Health Technology Insights: MHK Launches SmartProminence AI Solutions
The partnership combines BrightHeart’s innovative AI technology with the trusted Voluson ultrasound ecosystem through the Voluson Solution Store, which is the first digital marketplace for women’s health ultrasound and is accessible in both the United States and Europe. The collaboration aims to democratize access to expert-level prenatal care by making clinically validated AI tools for congenital defect screening and full exam support available to Voluson users. Developed in collaboration with leading fetal cardiology and maternal-fetal medicine experts and supported by strong clinical evidence, including two publications in The Green Journal, BrightHeart goes beyond basic quality checks. It delivers reliable insights that reduce diagnostic errors, improve detection of congenital defects, and enhance workflow efficiency.
Health Technology Insights: Artera Secures $65Million Growth Investment and Reaches $100Million CARR
BrightHeart’s cloud-based platform integrates seamlessly with Voluson ultrasound systems, supporting the entire prenatal care workflow from image acquisition to interpretation and review. This is particularly important as studies indicate that over 30 percent of congenital defects remain undetected prenatally. The U.S. also faces a shortage of sonographers and growing care deserts. Structural anomalies are detected in up to six percent of pregnancies, highlighting the critical role of ultrasound in early diagnosis and care planning. By providing BrightHeart’s AI to Voluson customers, the platform empowers OB/GYNs and maternal-fetal medicine specialists to perform more complete, confident exams, improving consistency, accuracy, and prenatal care at scale.
“Working closely with GE HealthCare allows us to bring best-in-class AI tools directly into the clinical workflows that clinicians rely on,” said Cécile Dupont, CEO of BrightHeart. “By combining our AI with Voluson ultrasound, we are helping care teams perform more complete and efficient exams while reinforcing our commitment to improving prenatal care outcomes.”
BrightHeart’s platform has already demonstrated benefits, including improved screening accuracy, reduced diagnostic errors, enhanced scan completeness, time savings, and increased clinician confidence.
“GE HealthCare has a long history of delivering clinically meaningful AI innovations to providers,” said Gerald Seifriedsberger, General Manager, Women’s Health Ultrasound, GE HealthCare. “By making BrightHeart’s B-Right AI Platform available through the Voluson Solution Store, we are putting clinically validated AI directly into the hands of our customers. This collaboration enables care teams to perform more consistent prenatal exams and improves the detection of congenital defects, supporting better outcomes for patients.”
Health Technology Insights: First Stop Health Joins ParetoHealth Network
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
